| Product Name | Odevixibat (Synonyms: A4250) | 
|---|---|
| CAS | 501692-44-0 | 
| Formula | C37H48N4O8S2 | 
| MW | 740.93 | 
| MDL | MFCD32710220 | 
| Appearance | White to off-white powder | 
| Storage condition | -20°C, stored under nitrogen | 
| Size | Availability | Price(USD) | VIP Price (USD) | Quantity | 
|---|---|---|---|---|
| 1 mg | 3-5 days | $70.00 | Visible after login | |
| 5 mg | 3-5 days | $166.00 | Visible after login | |
| 10 mg | 3-5 days | $266.00 | Visible after login | |
| 25 mg | 3-5 days | $428.00 | Visible after login | 
| Product Name | Odevixibat (Synonyms: A4250) | 
|---|---|
| CAS | 501692-44-0 | 
| Formula | C37H48N4O8S2 | 
| MW | 740.93 | 
| MDL | MFCD32710220 | 
| Appearance | White to off-white powder | 
| Storage condition | -20°C, stored under nitrogen | 
Odevixibat (A4250) is a selective and potent ASBT inhibitor that is taken orally. It has shown the ability to reduce cholestatic liver and bile duct injury in mouse models, positioning it as a potential treatment for primary biliary cirrhosis.
PMID: 26529078 DOI: 10.1016/j.jhep.2015.10.024